CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Net Income Growth by Quarter and Year

Mateon Therapeutics Inc's Net Income results by quarter and year




OXGN Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -3.78 -0.64 -3.88
III Quarter September - -0.99 -0.79 -3.96
II Quarter June 0.58 -1.19 -2.43 -3.10
I Quarter March -4.66 -0.68 -3.54 -3.64
FY   -4.08 -6.64 -7.40 -14.58



OXGN Net Income second quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc in the second quarter achieved Net Income of $ 0.58 millions compare to net loss recorded in same quarter a year ago.

According to the results reported in the second quarter, Mateon Therapeutics Inc achieved the best Net Income growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Net Income no change of % ranks overall at the positon no. 0 in the second quarter.




OXGN Net Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2020 Net Income $ 0.58 millions OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2019 Net Income $ -1.19 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Net Income Growth >>


OXGN Net Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q Net Income Comment
This reversal of fortune II. Quarter 2020where Mateon Therapeutics Inc published Net Income of $ 0.58 millions could be considered as a beginning of better performance.Mateon Therapeutics Inc announced in the II. Quarter 2020 Net Income of $ 0.58 millions compare to net loss recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Net Income growth. While Mateon Therapeutics Inc's Net Income growth quarter on quarter, overall rank is 0.


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q Net Income Comment
This reversal of fortune II. Quarter 2020where Mateon Therapeutics Inc posted Net Income of $ 0.58 millions could is starting point of improved business climet.Mateon Therapeutics Inc announced in the II. Quarter 2020 Net Income of $ 0.58 millions compare to net loss recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Net Income growth. While Mateon Therapeutics Inc's Net Income growth quarter on quarter, overall rank is 0.


Mateon Therapeutics Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Net Income 12 Months Ending $ -8.85 $ -10.62 $ -6.64 $ -3.50 $ -3.30
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months net loss of $ -9 millions in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months net loss of $ -9 millions in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
OXGN's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for OXGN's Competitors
Net Income Growth for Mateon Therapeutics Inc's Suppliers
Net Income Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2020
Mettler Toledo International Inc -0.47 %$ -0.470 millions
Lifevantage Corp -5.22 %$ -5.221 millions
Msa Safety Inc -9.24 %$ -9.239 millions
Catalyst Pharmaceuticals Inc -10.77 %$ -10.766 millions
Atrion Corporation -10.96 %$ -10.958 millions
Medpace Holdings inc -12.21 %$ -12.205 millions
Acadia Healthcare Company Inc -13.46 %$ -13.458 millions
Icu Medical Inc -17.19 %$ -17.190 millions
Amgen Inc -17.26 %$ -17.256 millions
Quest Diagnostics Inc -19.25 %$ -19.247 millions
Davita Inc -22.09 %$ -22.095 millions
Lemaitre Vascular Inc -24.31 %$ -24.308 millions
Vanda Pharmaceuticals Inc -24.40 %$ -24.397 millions
U S Physical Therapy Inc -25.44 %$ -25.439 millions
Neurotrope inc -26.83 %$ -26.833 millions
Baxter International Inc -27.99 %$ -27.988 millions
Five Star Senior Living Inc -28.20 %$ -28.199 millions
Pfizer Inc -32.08 %$ -32.081 millions
Bruker Corporation -34.59 %$ -34.595 millions
Johnson and Johnson -35.33 %$ -35.331 millions
Phibro Animal Health Corp -35.90 %$ -35.901 millions
Becton Dickinson And Company -36.59 %$ -36.585 millions
Abbott Laboratories -46.62 %$ -46.620 millions
United Therapeutics Corporation -47.78 %$ -47.782 millions
Abiomed Inc -49.86 %$ -49.858 millions
China Health Industries Holdings Inc -52.54 %$ -52.544 millions
Encompass Health Corporation -56.45 %$ -56.447 millions
Pacific Health Care Organization Inc -57.14 %$ -57.142 millions
Semler Scientific Inc -58.95 %$ -58.954 millions
Utah Medical Products Inc -62.75 %$ -62.752 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CAG's Profile

Stock Price

CAG's Financials

Business Description

Fundamentals

Charts & Quotes

CAG's News

Suppliers

CAG's Competitors

Customers & Markets

Economic Indicators

CAG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071